Unichem Laboratories Ltd Falls 8.59%: 4 Key Factors Driving the Weekly Decline

Monday, 20 July 2026: Technical Momentum Shifts Amid Mixed Signals

Unichem Laboratories began the week with a modest gain of 0.86%, closing at Rs.595.00, despite a flat Sensex. The stock’s technical momentum showed a nuanced shift from bullish to mildly bullish, with weekly MACD remaining positive but monthly MACD turning bearish. The weekly RSI indicated increasing selling pressure, while daily moving averages stayed bullish, suggesting short-term strength amid longer-term caution. This mixed technical landscape reflected investor uncertainty in the Pharmaceuticals & Biotechnology sector, with the stock trading well below its 52-week high of Rs.685.95 but comfortably above its low of Rs.280.00.

Wednesday, 22 July 2026: Intraday Low Amid Price Pressure

The stock faced significant selling pressure on 22 July, plunging 9.92% intraday to a low of Rs.527.80 and closing down 9.92% at that level. This decline was sharper than the Sensex’s 0.88% fall, highlighting company-specific weakness. Despite the broader Pharmaceuticals & Biotechnology sector showing resilience, Unichem underperformed, reflecting immediate market concerns. The stock traded below its 5-day moving average, signalling short-term weakness, although it remained above longer-term averages. Technical indicators presented a mixed picture: weekly MACD was bullish, but monthly MACD and RSI suggested caution. The Mojo Grade downgrade to Sell earlier in July likely contributed to the negative sentiment.

Thursday, 23 July 2026: Mojo Grade Upgraded to Hold Amid Technical Improvements

On 23 July, MarketsMOJO upgraded Unichem Laboratories’ Mojo Grade from Sell to Hold, reflecting improved technical indicators despite ongoing financial challenges. The stock closed at Rs.527.80, down 1.54% from the previous day’s close, but technical momentum shifted from mildly bullish to bullish. Weekly MACD and KST indicators turned positive, supported by bullish daily moving averages and mildly bullish Bollinger Bands. However, monthly MACD and KST remained bearish, indicating that longer-term momentum had yet to fully confirm a sustained uptrend. The company’s financials showed a 52.9% decline in profit before tax excluding other income and a 31.1% drop in profit after tax, underscoring ongoing challenges despite technical optimism.

Thursday, 23 July 2026: Technical Momentum Signals Bullish Outlook Despite Price Drop

Despite the sharp intraday price drop on 23 July, technical parameters suggested a cautiously optimistic outlook. The daily moving averages were firmly bullish, and weekly MACD indicated positive momentum. The Relative Strength Index remained neutral, implying no immediate oversold conditions. Bollinger Bands on weekly and monthly charts showed mild to strong bullishness, while Dow Theory assessments were mildly bullish. On-Balance Volume was bullish on a monthly scale, suggesting accumulation. This technical improvement underpinned the Mojo Grade upgrade and suggested potential for recovery, although investors were advised to remain cautious given the bearish monthly indicators and recent financial setbacks.

Friday, 24 July 2026: Modest Recovery Amid Continued Market Weakness

Unichem Laboratories closed the week on a positive note, gaining 1.62% to Rs.539.25. This recovery came despite the Sensex declining 0.32%, indicating relative strength. The stock’s volume was moderate, suggesting cautious buying interest. The technical outlook remained mixed, with short-term indicators supporting a rebound while longer-term signals remained cautious. The stock’s weekly decline of 8.59% contrasted with the Sensex’s 1.85% fall, highlighting significant underperformance but also potential for stabilisation after a volatile week.

Key Takeaways

Mixed Technical Signals: The week saw a transition from mildly bullish to bullish technical momentum, with short-term indicators improving while longer-term monthly signals remained cautious. This divergence suggests potential for recovery but warrants careful monitoring.

Significant Price Volatility: The stock experienced a sharp intraday drop of nearly 10% on 22 July, reflecting immediate selling pressure and underperformance relative to the Sensex and sector peers.

Mojo Grade Upgrade: The upgrade from Sell to Hold on 22 July was driven by improved technicals and a fair valuation, signalling cautious optimism despite ongoing financial challenges.

Financial Headwinds Persist: Recent quarterly results showed substantial declines in profitability, with profit before tax excluding other income down 52.9% and profit after tax down 31.1%, highlighting operational pressures.

Relative Outperformance Over Longer Terms: Despite short-term weakness, Unichem Laboratories has delivered strong returns over one-month, three-year, and five-year periods, outperforming the Sensex and indicating resilience.

Conclusion

Unichem Laboratories Ltd’s week was characterised by significant price volatility, mixed technical momentum, and a notable rating upgrade. While the stock declined 8.59% over the week, it outperformed the Sensex’s 1.85% fall on a relative basis. The upgrade to a Hold rating reflects improved technical indicators and a reasonable valuation, even as financial results remain under pressure. Investors should weigh the short-term technical optimism against longer-term cautionary signals and ongoing profit declines. Continued observation of technical trends and upcoming financial disclosures will be essential to assess whether Unichem Laboratories can sustain a recovery or face further headwinds.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today